Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Breckenridge Settles Actos Patent Litigation

By Pharmaceutical Processing | May 16, 2011

 

Breckenridge Pharmaceutical has announced that it and Synthon Pharmaceuticals have reached an agreement with
Takeda Pharmaceutical Company Limited and Takeda Pharmaceuticals North America
resolving patent litigation related to Pioglitazone Hydrochloride 15 mg, 30 mg
and 45 mg tablets, a generic equivalent version of Actos. Under the terms of
the agreement, Takeda granted Breckenridge and Synthon a non-exclusive,
royalty-free license to its U.S. patents covering Actos, permitting launch of
their generic-equivalent formulation of Actos after first-filers of ANDAs with
paragraph IV certifications exhaust their 180-day marketing exclusivity on
February 13, 2013, or earlier under certain circumstances, subject to
regulatory approval.

Breckenridge and Synthon signed a distribution and supply
agreement on the product in late 2009 and have been working together on this product,
including the settlement of the paragraph IV litigation.

Actos had approximately $3.4 billion in brand sales for the
twelve months ending December 31, 2009, according to IMS Health. Actos is a once-daily
oral prescription medication that, with diet and exercise, has been shown to be
effective for the treatment of type 2 diabetes.

 

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE